Vivos Inc.

Vivos Inc.

RDGL - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$20.36M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Vivos Inc.Vivos Inc.-5.4--185%--
$-0.03

Current Fair Value

162.9% downside

Overvalued by 162.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$20.36 Million
Enterprise Value$18.65 Million
Earnings per Share$-0.01
Beta-0.72
Outstanding Shares494,293,164

Return

Return on Equity-185.43%ROE
Return on Assets-167.44%
Return on Invested Capital-142.66%

Valuation & Multiples

P/E Ratio-5.37P/E Ratio
PEG-12.14PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue147.9
Enterprise Value to EBIT-6.14
Enterprise Value to Net Income-5
Total Debt to Enterprise0.01
Debt to Equity0.05Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS
-$0.00
Reported
Revenue
$28,900
Reported

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Vivos Inc.

1 employees
CEO: Michael K. Korenko

Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an i...

Vivos Insider Information FAQ

Stockcircle shows 11 open-market insider purchases for Vivos in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.